Popular Trials
Antiviral
Antiviral Therapy for Multiple Sclerosis
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is testing Truvada, an antiviral drug, to see if it can lower Epstein Barr virus levels in people with multiple sclerosis. The goal is to find a safer and more effective treatment for MS by targeting the virus. Truvada is already known to be safe from its use in treating HIV.
Popular Filters
Phase 3 Trials
Virus Therapy
Lenacapavir for HIV Prevention
Recruiting1 awardPhase 3
Los Angeles, California
This trial is testing lenacapavir, a drug that may help prevent HIV. It targets people who are at risk of getting HIV. The drug works by stopping the virus from making more copies of itself. Lenacapavir was developed by Gilead Sciences Inc. and has been approved for use in combination with other treatments.
Antiretroviral
PrEP for HIV Prevention in Transgender Women
Recruiting3 awardsPhase 2 & 3
San Francisco, California
This trial will test a new strategy to improve PrEP uptake and adherence among transgender people by integrating biomedical HIV prevention with gender-affirming transgender care and Peer Health Navigation using Strengths-Based Case Management.
Antiviral
F/TAF for HIV Pre-Exposure Prophylaxis
Recruiting1 awardPhase 3
Beverly Hills, California
This trial is testing whether a daily pill regimen of either emtricitabine/tenofovir alafenamide or emtricitabine/tenofovir disoproxil fumarate can help prevent HIV-1 infection in Men who have sex with men and transgender women.
Trials With No Placebo
Antiretroviral Therapy
Biktarvy vs. Symtuza for HIV-Related Weight Gain
Recruiting3 awardsPhase 4
Greenville, North Carolina
This trial compares two HIV treatments to see which one causes more weight gain. It focuses on people with HIV who are experiencing weight gain from their medications. Researchers will study tiny molecules called micro-RNAs to understand why this weight gain happens. One type of treatment has been associated with more weight gain compared to other treatments.
Antiretroviral Agent
PrEP + Hormone Therapy for HIV Prevention in Transgender Women
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial is to study the best way to dose Truvada®, an oral medication that can be taken as Pre-Exposure Prophylaxis (PrEP) to prevent HIV infection, in transgender women who are also taking feminizing hormones.
Antiretroviral
PrEP for HIV Prevention in Transgender Women
Recruiting3 awardsPhase 2 & 3
San Francisco, California
This trial will test a new strategy to improve PrEP uptake and adherence among transgender people by integrating biomedical HIV prevention with gender-affirming transgender care and Peer Health Navigation using Strengths-Based Case Management.
Antiretroviral
Stribild +1 More for HIV/AIDS
Recruiting5 awardsPhase 4
Honolulu, Hawaii
Atripla and Stribild are two FDA-Approved one pill a day combination antiretroviral medications given for the treatment of HIV. Both drugs are reasonably well tolerated. However, efavirenz, a component of Atripla, is known to cause "mental" side effects. This proposal aims to assess whether a switch from Atripla to Stribild for 12 weeks will be associated with reversal of sleep and cognitive disturbances. Demonstrating changes upon withdrawal of drug and substitution of a drug regimen not known to have an impact on sleep and cognition may represent the best option to determine whether use of efavirenz is associated with effects on sleep and cognition beyond the immediate period following initiation of drug.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.